Synopsis
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
85
PharmaCompass offers a list of Chondroitin Sulfate Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Chondroitin Sulfate Sodium manufacturer or Chondroitin Sulfate Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Chondroitin Sulfate Sodium manufacturer or Chondroitin Sulfate Sodium supplier.
A Sodium Chondroitin Sulphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Chondroitin Sulphate, including repackagers and relabelers. The FDA regulates Sodium Chondroitin Sulphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Chondroitin Sulphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sodium Chondroitin Sulphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Sodium Chondroitin Sulphate supplier is an individual or a company that provides Sodium Chondroitin Sulphate active pharmaceutical ingredient (API) or Sodium Chondroitin Sulphate finished formulations upon request. The Sodium Chondroitin Sulphate suppliers may include Sodium Chondroitin Sulphate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium Chondroitin Sulphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Sodium Chondroitin Sulphate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium Chondroitin Sulphate active pharmaceutical ingredient (API) in detail. Different forms of Sodium Chondroitin Sulphate DMFs exist exist since differing nations have different regulations, such as Sodium Chondroitin Sulphate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium Chondroitin Sulphate DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium Chondroitin Sulphate USDMF includes data on Sodium Chondroitin Sulphate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium Chondroitin Sulphate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium Chondroitin Sulphate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Sodium Chondroitin Sulphate Drug Master File in Japan (Sodium Chondroitin Sulphate JDMF) empowers Sodium Chondroitin Sulphate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Sodium Chondroitin Sulphate JDMF during the approval evaluation for pharmaceutical products. At the time of Sodium Chondroitin Sulphate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Sodium Chondroitin Sulphate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Sodium Chondroitin Sulphate Drug Master File in Korea (Sodium Chondroitin Sulphate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Sodium Chondroitin Sulphate. The MFDS reviews the Sodium Chondroitin Sulphate KDMF as part of the drug registration process and uses the information provided in the Sodium Chondroitin Sulphate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Sodium Chondroitin Sulphate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Sodium Chondroitin Sulphate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Sodium Chondroitin Sulphate suppliers with KDMF on PharmaCompass.
A Sodium Chondroitin Sulphate CEP of the European Pharmacopoeia monograph is often referred to as a Sodium Chondroitin Sulphate Certificate of Suitability (COS). The purpose of a Sodium Chondroitin Sulphate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Sodium Chondroitin Sulphate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Sodium Chondroitin Sulphate to their clients by showing that a Sodium Chondroitin Sulphate CEP has been issued for it. The manufacturer submits a Sodium Chondroitin Sulphate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Sodium Chondroitin Sulphate CEP holder for the record. Additionally, the data presented in the Sodium Chondroitin Sulphate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Sodium Chondroitin Sulphate DMF.
A Sodium Chondroitin Sulphate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Sodium Chondroitin Sulphate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Sodium Chondroitin Sulphate suppliers with CEP (COS) on PharmaCompass.
A Sodium Chondroitin Sulphate written confirmation (Sodium Chondroitin Sulphate WC) is an official document issued by a regulatory agency to a Sodium Chondroitin Sulphate manufacturer, verifying that the manufacturing facility of a Sodium Chondroitin Sulphate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Sodium Chondroitin Sulphate APIs or Sodium Chondroitin Sulphate finished pharmaceutical products to another nation, regulatory agencies frequently require a Sodium Chondroitin Sulphate WC (written confirmation) as part of the regulatory process.
click here to find a list of Sodium Chondroitin Sulphate suppliers with Written Confirmation (WC) on PharmaCompass.
Sodium Chondroitin Sulphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Chondroitin Sulphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sodium Chondroitin Sulphate GMP manufacturer or Sodium Chondroitin Sulphate GMP API supplier for your needs.
A Sodium Chondroitin Sulphate CoA (Certificate of Analysis) is a formal document that attests to Sodium Chondroitin Sulphate's compliance with Sodium Chondroitin Sulphate specifications and serves as a tool for batch-level quality control.
Sodium Chondroitin Sulphate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Chondroitin Sulphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Chondroitin Sulphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Chondroitin Sulphate EP), Sodium Chondroitin Sulphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Chondroitin Sulphate USP).
